Associates L P Venrock IV's Net Worth

$19.2 Million

Estimate Recalculated Apr 2, 2024 11:03AM EST

Who is Associates L P Venrock IV?

Associates L P Venrock IV has an estimated net worth of $19.2 Million. This is based on reported shares across multiple companies, which include QUANTENNA COMMUNICATIONS INC, Anacor Pharmaceuticals, Inc., Bellerophon Therapeutics, Inc., ALIMERA SCIENCES INC, ACCELERON PHARMA INC, and Achaogen Inc.

SEC CIK

Associates L P Venrock IV's CIK is 0001277997

Past Insider Trading and Trends

2018 was Associates L P Venrock IV's most active year for acquiring shares with 24 total transactions. Associates L P Venrock IV's most active month to acquire stocks was the month of August. 2016 was Associates L P Venrock IV's most active year for disposing of shares, totalling 7 transactions. Associates L P Venrock IV's most active month to dispose stocks was the month of October. 2010 saw Associates L P Venrock IV paying a total of $6,366,781.00 for 6,574,605 shares, this is the most they've acquired in one year. In 2013 Associates L P Venrock IV cashed out on 150,000 shares for a total of $2,109,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

QUANTENNA COMMUNICATIONS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.65M
—
—
2.65M
Nov 2
Form 3
—
0
—
—
0
No matching records found

Anacor Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.03%
-150.00K
$14.06
-$2,109,000.00
3.58M
Nov 15
Form 4
-0.51%
-19.27K
$6.30
-$121,456.52
3.73M
Sep 20
Form 4
-0.93%
-35.00K
$6.51
-$227,804.50
3.74M
Sep 14
Form 4
-0.66%
-25.18K
$6.59
-$165,932.26
3.78M
Sep 11 - Sep 13
Form 4
-17.74%
-820.55K
—
—
3.8M
Jul 2
Form 4
∞
2.63M
$5.00
—
2.63M
Nov 30
Form 3
—
0
—
—
0
No matching records found

Bellerophon Therapeutics, Inc. (BLPH) Snapshot price: $0.036

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.53%
-1.09M
$0.48
-$524,957.25
6.44M
Oct 24 - Oct 28
Form 4
-14.53%
-1.09M
$0.48
-$524,957.25
6.44M
Oct 24 - Oct 28
Form 4
+1.93%
142.86K
$0.70
$99,999.90
7.53M
Jan 23
Form 4
+1.93%
142.86K
$0.70
$99,999.90
7.53M
Jan 23
Form 4
+2.93%
210K
$1.20
$252,354.00
7.39M
Sep 13 - Sep 17
Form 4
+2.93%
210K
$1.20
$252,354.00
7.39M
Sep 13 - Sep 17
Form 4
+7.09%
475K
$1.18
$558,392.50
7.18M
Sep 10 - Sep 12
Form 4
+7.09%
475K
$1.18
$558,392.50
7.18M
Sep 10 - Sep 12
Form 4
+2.45%
160K
$0.86
$138,162.00
6.7M
Sep 5 - Sep 7
Form 4
+2.45%
160K
$0.86
$138,162.00
6.7M
Sep 5 - Sep 7
Form 4
+8.81%
529.37K
$0.65
$342,879.06
6.54M
Aug 14 - Aug 16
Form 4
+8.81%
529.37K
$0.65
$342,879.06
6.54M
Aug 14 - Aug 16
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

ALIMERA SCIENCES INC (ALIM) Snapshot price: $3.93

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.90%
-838.71K
—
—
6.21M
May 6
Form 4
∞
3.95M
$11.00
—
3.95M
Apr 27
Form 3
—
0
—
—
0
No matching records found

ACCELERON PHARMA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found